Dr. Öğr. Üyesi Sıla GÜLBAĞ PINAR

Yayın Ağı

Makaleler 14

1. Advanced skin delivery systems: Formulation strategies, therapeutic potential and patent perspectives

Türkmen E., Pınar S. G., Kara A. A., Oktay A. N., Çelebi N.

Journal of Drug Delivery Science and Technology , cilt.125, 2026 (SCI-Expanded, Scopus)

2. C Vitamini, D Vitamini ve Arjinin İçeren Yenilikçi Yumuşak Şeker Tablet Takviye Edici Gıdanın Geliştirilmesi ve Değerlendirilmesi: Önformülasyon Çalışması

TOPRAK N. N., PINAR S. G.

Farabi tıp dergisi , cilt.5, sa.1, 2026 (TRDizin)

3. Oral cyclosporine a nanosuspension for improved immunosuppressive efficacy: In vivo cytokine profiling in rats

TAN Ç., Gülbağ Pınar S., Çelebi N.

Transplant Immunology , cilt.93, 2025 (SCI-Expanded, Scopus)

4. Development of Cyclosporine A Nanosuspension Using an Experimental Design Based on Response Surface Methodology: In Vitro Evaluations

GÜLBAĞ PINAR S., Çelebi N.

Turkish Journal of Pharmaceutical Sciences , cilt.21, sa.5, ss.428-439, 2024 (ESCI, Scopus, TRDizin)

5. Preparation and in vitro characterization of memantine HCl loaded PLGA nanoparticles for Alzheimer's disease

Tezel G., Ulutürk S., REÇBER T., TİMUR S. S., NEMUTLU E., ESENDAĞLI G., et al.

Journal of Drug Delivery Science and Technology , cilt.100, 2024 (SCI-Expanded, Scopus)

6. Evaluation of the Mixture "MagSelDex" For Neuroprotection Against Offspring Brain Injury in Endotoxin-Induced Chorioamnionitis: A Preliminary Study

aşcı h., SAVRAN M., GÜLBAG PINAR S., KARAKUYU N. F., İmeci O., Sevük M. A., et al.

Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi , cilt.15, sa.1, ss.48-61, 2024 (TRDizin)

7. Formulation Strategies of Nanosuspensions for Various Administration Routes

Pınar S., Oktay A. N., Karaküçük A. E., Çelebi N.

Pharmaceutics , cilt.15, sa.5, 2023 (SCI-Expanded, Scopus)

8. Uçuk Tedavisinde Kullanılmak Üzere Antiviral Etkin Madde İçeren Dudak Balmı (Lip Balm) Formülasyonunun Geliştirilmesi

Cengiz R. N., GÜLBAG PINAR S.

Süleyman Demirel Üniversitesi Sağlık Bilimleri Dergisi , cilt.14, sa.1, ss.64-77, 2023 (TRDizin)

9. The Possible Protective Effect of Boric Acid in an Alkaline-Induced Corneal Neovascularization Rat Model

KARACA U., GÜLBAĞ PINAR S., SAVRAN M., USTA SOFU G., İLHAN İ., ÖZKAYA D., et al.

BIOLOGICAL TRACE ELEMENT RESEARCH , cilt.200, sa.12, ss.5127-5133, 2022 (SCI-Expanded, Scopus)

10. A new nanosuspension prepared with wet milling method for oral delivery of highly variable drug Cyclosporine A: development, optimization and in vivo evaluation

Pınar S., CANPINAR H., TAN Ç., Çelebi N.

European Journal of Pharmaceutical Sciences , cilt.171, 2022 (SCI-Expanded, Scopus)

11. Development of cyclosporine A nanosuspension: cytotoxicity and permeability on Caco-2 cell lines

Pinar S., PEZİK E., MUTLU AĞARDAN N. B., Celebi N.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.27, sa.1, ss.52-62, 2022 (SCI-Expanded, Scopus)

12. Optimization and evaluation of cyclosporine A nanosuspension stabilized by combination stabilizers using high pressure homogenization method

Pinar S., Celebi N.

JOURNAL OF RESEARCH IN PHARMACY , cilt.23, sa.6, ss.1009-1021, 2019 (ESCI, Scopus, TRDizin)

13. New perspective to develop memantine orally disintegrating tablet formulations: SeDeM expert system

Gulbag S., Usta D. Y., Gultekin H. E., Oktay A. N., Demirtas O., Karakucuk A., et al.

PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY , cilt.23, sa.5, ss.512-519, 2018 (SCI-Expanded, Scopus)

14. Cyclosporine A and New Approaches to Cylosporine A Formulations

GÜLBAĞ S., ÇELEBİ F. N.

FABAD Journal of Pharmaceutical Sciences , 2017 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 19

1. Evaluation of Biochemical and Immunological Parameters of New Developed Cyclosporine A Nanosuspension

Gülbağ Pınar S., Fidan H. K., Tan Ç., Çelebi F. N.

20th International Pharmaceutical Technology Symposium (IPTS 2022), Ankara, Türkiye, 21 - 23 Şubat 2022, ss.105-107, (Tam Metin Bildiri)

2. Memantine Loaded PLGA Nanoparticles for Alzheimer’s Disease Part-1: In-vitro Characterization

Tezel G., Reçber T., Timur S. S., Nemutlu E., Gülbağ Pınar S., Eroğlu H.

20th International Pharmaceutical Technology Symposium (IPTS 2022), Ankara, Türkiye, 21 - 23 Şubat 2022, ss.211-213, (Tam Metin Bildiri)

3. Covid-19 Tedavisinde Kullanılan Antiviral İlaçların Biyofarmasötik Yönden Değerlendirilmesi

Gülbağ Pınar S., Çelebi F. N.

3. Ulusal Sağlık Hizmetleri Sempozyumu, Isparta, Türkiye, 19 - 20 Kasım 2021, ss.103-106, (Tam Metin Bildiri) Sürdürülebilir Kalkınma

4. The Effects of a New Cyclosporine A Nanosuspension on Nephrotoxicity After Oral Administration: HK-2 Cell Culture and In Vivo Histopathological Evaluation

Gülbağ Pınar S., Mutlu Ağardan N. B., Işık Gönül İ., Çelebi F. N.

Gazi Pharma Semposium Series (GPSS) 3, Ankara, Türkiye, 8 - 10 Eylül 2021, ss.31-32, (Özet Bildiri)

5. Reçete Türleri ve Beşeri İlaç Şekillerine Kavramsal Yaklaşım - Conceptual Approach to Prescription Types And Human Drug Forms

Gülbağ Pınar S.

I. Uluslararası İlaç ve Eczacılık Hukuku Kongresi, Ankara, Türkiye, 4 - 05 Eylül 2021, ss.2-3, (Tam Metin Bildiri)

6. Immunological Effects of A New Developed Cyclosporine A Nanosuspension in Rats for Oral Administration

Gülbağ Pınar S., Tan Ç., Atak Yücel A., Çelebi F. N.

13th International Symposium on Pharmaceutical Sciences (ISOPS-13), Ankara, Türkiye, 22 - 25 Haziran 2021, ss.48-49, (Özet Bildiri)

7. Cyclosporine A nanosuspension prepared with wet milling method using combined stabilizers: Pharmacokinetic and immunological evaluation in rats

Gülbağ Pınar S., Canpınar H., Çelebi F. N.

EUFEPS Annual Meeting 2021: Bridging the Gap Between the Patient and the Product Design, Gothenburg, İsveç, 7 - 09 Haziran 2021, ss.35, (Özet Bildiri)

8. Evaluation of Dissolution Properties of Cyclosporine a Nanosuspensions Prepared with Two Different Top Down Technologies

Gülbağ S., Mutlu Ağardan N. B., Çelebi F. N.

8th BBBB Conference on Pharmaceutical Sciences, İzmir, Türkiye, 14 - 16 Ekim 2019, ss.85-86, (Tam Metin Bildiri)

9. The Effects of Process Parameters of the Cyclosporine A Nanosuspension Produced by Wet Milling Stabilized with Hydroxypropyl methylcellulose

Gülbağ Pınar S., Karaküçük A. E., Mutlu Ağardan N. B., Çelebi F. N.

The 2019 Controlled Release Society Annual Meeting & Exposition (CRS 2019), Valencia, İspanya, 21 - 24 Temmuz 2019, (Özet Bildiri)

10. Development and Evaluation of Nanosuspension Formulations for Poorly Soluble Drugs Using Top Down Technologies

Gülbağ Pınar S., Oktay A. N., Çelebi F. N.

International Multidisciplinary Symposium on Drug Research and Development (DRD 2019), Malatya, Türkiye, 1 - 03 Temmuz 2019, ss.92-94, (Tam Metin Bildiri)

11. Cyclosporine A Nanosuspension Produced by Wet Media Milling Method: Development and Characterization

Gülbağ Pınar S., Çelebi F. N.

EUFEPS Annual Meeting 2019: Personalized Medicines, Targeted Therapies, Precision Drug Delivery, Frankfurt, Almanya, 6 - 08 Mart 2019, ss.115-116, (Özet Bildiri)